The impact of syringe deregulation on sources of syringes for injection drug users: Preliminary findings

AIDS and Behavior

Volumn 10, Issue 6, 2006, Pages 717-721

  Deren, Sherry ^a,d   Cleland, Charles M ^a   Fuller, Crystal ^b   Kang, Sung Yeon ^a   Des Jarlais, Don C ^a,c   Vlahov, David ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Injection drug use; Pharmacy; Syringe access

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEREGULATION; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH PROGRAM; HEALTH SERVICE; HOSPITAL DEPARTMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRESCRIPTION; SYRINGE; UNITED STATES;

HUMANS; LEGISLATION, PHARMACY; LONGITUDINAL STUDIES; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 33750299640     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-006-9096-4     Document Type: Article

References (12)

1. Carneiro, M., Fuller, C., Doherty, M., and Vlahov, D. (1999). HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug and Alcohol Dependence, 54, 83-86.
2. Center for Urban Epidemiologic Studies, New York Academy of Medicine, Beth Israel Medical Center, and National Development and Research Institutes, Inc. (2003). New York State Expanded Syringe Access Demonstration Program Evaluation. New York: New York Academy of Medicine.
3. Colón, H. M., Robles, R. R., Deren, S., Sahai, H., Finlingon, H., Andia, J., et al. (2003). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York and Bayamon, Puerto Rico. Journal of Psychoactive Drugs, 35, 197-207.
4. Deren, S., Fuller, C., Pouget, E. R., Blaney, S., Tortu, S., Kang, S. Y., et al. (2003). Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. International Journal of Drug Policy, 14, 373-379.
5. Deren, S., Oliver-Velez, D., Finlinson, A., Robles, R. R., Andia, J., Colón, H. M., et al. (2003). Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse, 38, 1-24.
6. Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., et al. (2000). HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352-359.
7. Des Jarlais, D. C., McKnight, C., and Friedmann, P. (2002). Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S73-S76.
8. Fuller, C., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D. C., et al. (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease, 14, 589-596.
9. Hagan, H., Thiede, H., and Des Jarlais, D. C. (2004). Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology, 15, 543-549.
10. Klein, S. J., Estel, G. R., Candelas, A. R., and Plavin, H. A. (2002). Promoting safe syringe disposal goes "hand in hand" with Expanded Syringe Access in New York State. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S29-S31.
11. Normand, J., Vlahov, D., and Moses, L. E. (eds.). (1995). Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy of Medicine.
12. Pouget, E. R., Deren, S., Fuller, C., Blaney, S., McMahon, J., Kang, S. Y., et al. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39, 471-477.